Digital Symptom Tracking for Advanced Cancer

Recruiting at 1 trial location

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Stanford University

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

41 Participants Needed

Trial Summary

What is the purpose of this trial?

This trial involves cancer patients using the Noona app to log their symptoms. The app helps track symptoms and alerts patients to contact their clinical team if severe symptoms occur. This approach aims to improve symptom management and patient care. Noona is an internet-based system for patients to report symptoms and adverse events of cancer treatments from home.

Research Team

Kavitha Ramchandran, MD

Principal Investigator

Stanford University

Eligibility Criteria

This trial is for adults over 18 with advanced lung or gastrointestinal cancer, who can use a smartphone, tablet, or computer. They should be able to perform daily activities (ECOG status 0-2), have no limit on previous treatments in the metastatic setting, and are expected to live at least another 6 months. Non-English speakers and those with conditions that could interfere with participation or safety are excluded.

Inclusion Criteria

I have a smartphone, tablet, or computer to use a symptom tracking app.

I am 18 years old or older.

I am able to get out of my bed or chair and move around.

Exclusion Criteria

My prostate cancer responds to hormone therapy.

I am able to communicate in English.

Enrolled in other non-therapeutic or therapeutic clinical trials

Treatment Details

Interventions

• Use of Noona web-based symptom tracking tool

Trial Overview The study tests the Noona web-based symptom tracking tool's impact on patient engagement and quality of life. Participants will log symptoms regularly using their devices and complete a Symptom Questionnaire before oncology visits for real-time symptom management over a period of 24 weeks.

Participant Groups

Group I: Noona web-based symptom tracking tool Experimental Treatment 1 Intervention

In addition to usual care for their disease, patients interact with Noona system and system questioners to record their symptoms over a period of 6 months.

Group II: Usual Care Active Control 1 Intervention

Participants will receive the standard of care for their disease

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials

2,527

Recruited

17,430,000+

Varian Medical Systems

Industry Sponsor

Trials

63

Recruited

3,700+

Dow R. Wilson

Varian Medical Systems

Chief Executive Officer since 2012

MBA from Dartmouth's Amos Tuck School of Business, BA from Brigham Young University

Dr. Deepak Khuntia

Varian Medical Systems

Chief Medical Officer since 2020

MD from the University of Cambridge, PhD from the University of Leicester